Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20153397rdf:typepubmed:Citationlld:pubmed
pubmed-article:20153397lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C0005953lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:20153397lifeskim:mentionsumls-concept:C2348480lld:lifeskim
pubmed-article:20153397pubmed:issue6lld:pubmed
pubmed-article:20153397pubmed:dateCreated2010-5-20lld:pubmed
pubmed-article:20153397pubmed:abstractTextEx vivo identification of donor-specific unresponsiveness in organ transplant recipients is important for immunosuppression (IS) minimization. We tested three groups of stable living, related-donor kidney transplant patients up to 11 years postoperatively, i.e., 20 haploidenticals with donor bone marrow cell (DBMC) infusions, eight noninfused haploidentical controls (haplo controls), and 11 HLA-identical controls (HLA-id), using multiple ex vivo immune assays. We observed that no patients developed donor-specific antibodies. The majority showed donor-specific CTL unresponsiveness from year 1 onward. Thirteen of 20 DBMC recipients became specifically donor MLR nonreactive. Depletion of donor cells in DBMC recipients still MLR reactive increased donor-specific reactivity by 75% +/- 36% (p = 0.04). Adding them back in low concentration caused antigen specific inhibition. The frequencies of ELISPOT granzyme-B and interferon-gamma-producing cells somewhat paralleled the CTL and MLR responses. In the trans vivo DTH, 14 of 19 DBMC recipients demonstrated donor-specific unresponsiveness and 16 of 19 showed "linked suppression," vs none of eight and one of eight haplo controls and vs six of 10 and one of 10 HLA-ids, respectively. Most importantly, when all six assays were performed simultaneously, 10 of 18 DBMC, five of 10 HLA-ids, and no haplo controls were specifically donor unresponsive long term. We propose that a cluster analysis combining these assays will reveal tolerant recipients in whom IS minimization may safely be tested. This appears to have occurred in many DBMC-infused recipients.lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:languageenglld:pubmed
pubmed-article:20153397pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:citationSubsetIMlld:pubmed
pubmed-article:20153397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20153397pubmed:statusMEDLINElld:pubmed
pubmed-article:20153397pubmed:monthJunlld:pubmed
pubmed-article:20153397pubmed:issn1879-1166lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:RicordiCamill...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:BurkeGeorge...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:WangEdwardElld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:MillerJoshuaJlld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:CiancioGaetan...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:RosenAnneAlld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:EsquenaziViol...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:FullerLaphall...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:BlombergBonni...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:MathewJames...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:Garcia-Morale...lld:pubmed
pubmed-article:20153397pubmed:authorpubmed-author:GomezCarmen...lld:pubmed
pubmed-article:20153397pubmed:copyrightInfoCopyright 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20153397pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20153397pubmed:volume71lld:pubmed
pubmed-article:20153397pubmed:ownerNLMlld:pubmed
pubmed-article:20153397pubmed:authorsCompleteYlld:pubmed
pubmed-article:20153397pubmed:pagination566-76lld:pubmed
pubmed-article:20153397pubmed:dateRevised2011-7-28lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
pubmed-article:20153397pubmed:meshHeadingpubmed-meshheading:20153397...lld:pubmed
More...